# Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension

> **NCT04908397** · PHASE1 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension
- Familial Primary Pulmonary Hypertension
- Primary Pulmonary Hypertension
- Lung Diseases
- Carnitine Nutritional Deficiency

## Interventions

- **DIETARY_SUPPLEMENT:** L-carnitine

## Key facts

- **NCT ID:** NCT04908397
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-29
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04908397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04908397, "Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04908397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*